Haiyan Xu
- Molecular Biology
- Cancer Research top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Pharmacology top 5%
- Co-authors
- Yuanyuan ZhangRui YangLinhui GuYi JinJianguo FengDafang ZhongStephen W.J. WangKaustubh H. Kulkarni
- Topics
- Cardiac Valve Diseases and Treatments (7 papers)Cardiovascular Function and Risk Factors (6 papers)Cancer-related molecular mechanisms research (6 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaMolecular Cell
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Haiyan Xu
95 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 531
- Cancer Research 182
- Cardiology and Cardiovascular Medicine 177
- Oncology 157
- Pharmacology 113
Countries citing papers authored by Haiyan Xu
This map shows the geographic impact of Haiyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Xu more than expected).
Fields of papers citing papers by Haiyan Xu
This network shows the impact of papers produced by Haiyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Xu. The network helps show where Haiyan Xu may publish in the future.
Co-authorship network of co-authors of Haiyan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Xu. A scholar is included among the top collaborators of Haiyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Xu. Haiyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 23 | |
| 9 | 12 | |
| 10 | 2 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 16 | |
| 15 | 8 | |
| 16 | 25 | |
| 17 | 1 | |
| 18 | 28 | |
| 19 | 8 | |
| 20 | [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication]. | 3 |
About Haiyan Xu
Haiyan Xu is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Complementary and alternative medicine, having authored 105 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Pharmacology (113 citations), Cancer Research (182 citations) and Complementary and alternative medicine (66 citations). Haiyan Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuanyuan Zhang, Rui Yang, Linhui Gu, Yi Jin, Jianguo Feng, Dafang Zhong, Stephen W.J. Wang, Kaustubh H. Kulkarni, Rashim Singh and Ming Hu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.